Bayer Aktiengesellschaft (WSE:BAY)

Poland flag Poland · Delayed Price · Currency is PLN
122.26
+5.30 (4.53%)
Oct 10, 2025, 11:25 AM CET
4.53%
Market Cap117.29B
Revenue (ttm)195.87B
Net Income (ttm)-14.50B
Shares Outn/a
EPS (ttm)-14.76
PE Ration/a
Forward PE5.93
Dividend0.47 (0.38%)
Ex-Dividend DateApr 28, 2025
Volume16
Average Volume10
Open119.98
Previous Close116.96
Day's Range119.98 - 122.26
52-Week Range78.97 - 127.50
Betan/a
RSI56.21
Earnings DateNov 12, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin... [Read more]

Sector Healthcare
Founded 1863
Employees 91,864
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BAY
Full Company Profile

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR Financial Statements

News

There is no news available yet.